MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

10.30.2014

A survey of TB diagnostic and treatment practices in eight countries, October 2014.

Iraq experienced a dramatic surge in violence in 2014 that triggered successive large-scale waves of displacement. More than 2.6 million people are said to have fled war-torn the central and northern areas of Iraq, particularly Al-Anbar, Ninawa, Salah Al-Din, Kirkuk and Diyala governorates.

MSF briefing paper, December 2014

What began in 2011 in Syria as protests inspired by the Arab Spring has become an entrenched and bloody conflict that shows no sign of resolution. Today, with an estimated 200,000 people killed and 7.6 million people displaced within the country and 3.2 million refugees registered outside, Syria is seen as the world’s most grave humanitarian disaster. In the face of this crisis, the previously functioning health system has collapsed and scores of thousands of medical staff have fled.

June 02, 2016

India must resist pressure from US lawmakers and pharmaceutical industry groups to block access to key medicines for millions of people worldwide

May 26, 2016

New York/Ise-Shima/Geneva—As the leaders of the G7 countries gather in Ise-Shima, Japan over the next two days, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to make a bold commitment to prioritize a better global response to public health emergencies and to take action to encourage the research and development (R&D) and affordable pricing of critical medicines.

May 16, 2016

US officials are expected to use this week’s APEC meeting to discuss extending the length of monopoly market protection for biologic medicines and vaccines.

May 03, 2016

Speech by Dr. Joanne Liu

International President, Médecins Sans Frontières (MSF)

United Nations Security Council Briefing

May 3, 2016, New York, USA

 

Excellencies,

Ladies and gentlemen,

Last Wednesday, airstrikes obliterated Al Quds Hospital in Aleppo.

They blew apart at least 50 men, women and children.

April 29, 2016

NEW YORK—The United States military today released its investigative report on the attack on the Doctors Without Borders/Médecins Sans Frontières (MSF) trauma hospital in Kunduz, Afghanistan, on October 3, 2015. The attack killed 42 people, including 14 MSF staff members, and wounded dozens more.

April 27, 2016

MSF hands over global petition as volunteers place 2,500 flowers in front of Pfizer’s headquarters in New York, representing the number of kids who die of pneumonia each day.

April 12, 2016

More than fifty groups have come together to demand that the US Congress reject the Trans-Pacific Partnership Trade Deal (TPP) due to provisions it contains that would undermine public health. In a letter sent to Congress today, the groups outlined the damaging effects the trade deal would have on public health, and said lawmakers should not vote for the TPP unless damaging provisions are removed.

March 18, 2016

Statement by Judit Rius Sanjuan, Doctors Without Borders/Médecins Sans Frontières’ (MSF) US Access Campaign Manager and Legal Policy Adviser 

March 10, 2016

Judit Rius Sanjuan, Access Campaign manager & legal policy advisor at Doctors Without Borders/Médecins Sans Frontières (MSF), made the following statement after KaloBios Pharmaceuticals obtained bankruptcy court permission to keep pursing a drug that could receive a US Federal Drug Administration Priority Review Voucher (PRV).

March 09, 2016

New York— A Senate committee voted today to add Zika to the list of diseases eligible for the US Federal Drug Administration (FDA) Priority Review Voucher (PRV) program for neglected diseases, but did not fix major loopholes that make the PRV program for neglected diseases ripe for abuse by pharmaceutical companies.

Pages